• Home >>
  • Materials and Chemicals

Global Neurodegenerative Diseases Industry Market Trends By Regional Analysis (America, Europe, Asia Pacific, and Middle East & Africa) Growth Opportunity and Industry Forecast 2021-2027

  • ID : 1492763
  • Date : 01 Feb 2021
  • Region : Global
  • Pages :114

CHOOSE LICENCE TYPE

Neurodegenerative disease is an umbrella term for a range of conditions which primarily affect the neurons in the human brain. Neurons are the building blocks of the nervous system which includes the brain and spinal cord. Neurons normally don’t reproduce or replace themselves, so when they become damaged or die they cannot be replaced by the body. Examples of neurodegenerative diseases include Parkinson’s, Alzheimer’s, and Huntington’s disease. Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and / or death of nerve cells. This causes problems with movement (called ataxias), or mental functioning (called dementias). Dementias are responsible for the greatest burden of neurodegenerative diseases, with Alzheimer’s representing approximately 60-70% of dementia cases. The Neurodegenerative Diseases market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform. In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Neurodegenerative Diseases industry. Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain. In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy. The Neurodegenerative Diseases market can be split based on product types, major applications, and important countries as follows: Key players in the global Neurodegenerative Diseases market covered in Chapter 12: Biogen Idec Alector Bayer Asubio Pharmaceutical Addex Pharmaceutical Amarin Yumanity Therapeutics Pfizer Boehringer Ingelheim UCB Merck AstraZeneca H.Lundbeck A/S Novartis Teva Eisai Bial In Chapter 4 and 14.1, on the basis of types, the Neurodegenerative Diseases market from 2015 to 2025 is primarily split into: NMDA SSRIs Dopamine Inhibitors In Chapter 5 and 14.2, on the basis of applications, the Neurodegenerative Diseases market from 2015 to 2025 covers: Parkinson’s Disease Huntington Disease Amyotrophic Lateral Sclerosis Alzheimer’s Disease Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14: North America (Covered in Chapter 7 and 14) United States Canada Mexico Europe (Covered in Chapter 8 and 14) Germany UK France Italy Spain Russia Others Asia-Pacific (Covered in Chapter 9 and 14) China Japan South Korea Australia India Southeast Asia Others Middle East and Africa (Covered in Chapter 10 and 14) Saudi Arabia UAE Egypt Nigeria South Africa Others South America (Covered in Chapter 11 and 14) Brazil Argentina Columbia Chile Others Years considered for this report: Historical Years: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Period: 2020-2025

Table of Content 1 Neurodegenerative Diseases Introduction and Market Overview 1.1 Objectives of the Study 1.2 Overview of Neurodegenerative Diseases 1.3 Scope of The Study 1.3.1 Key Market Segments 1.3.2 Players Covered 1.3.3 COVID-19's impact on the Neurodegenerative Diseases industry 1.4 Methodology of The Study 1.5 Research Data Source 2 Executive Summary 2.1 Market Overview 2.1.1 Global Neurodegenerative Diseases Market Size, 2015 – 2020 2.1.2 Global Neurodegenerative Diseases Market Size by Type, 2015 – 2020 2.1.3 Global Neurodegenerative Diseases Market Size by Application, 2015 – 2020 2.1.4 Global Neurodegenerative Diseases Market Size by Region, 2015 - 2025 2.2 Business Environment Analysis 2.2.1 Global COVID-19 Status and Economic Overview 2.2.2 Influence of COVID-19 Outbreak on Neurodegenerative Diseases Industry Development 3 Industry Chain Analysis 3.1 Upstream Raw Material Suppliers of Neurodegenerative Diseases Analysis 3.2 Major Players of Neurodegenerative Diseases 3.3 Neurodegenerative Diseases Manufacturing Cost Structure Analysis 3.3.1 Production Process Analysis 3.3.2 Manufacturing Cost Structure of Neurodegenerative Diseases 3.3.3 Labor Cost of Neurodegenerative Diseases 3.4 Market Distributors of Neurodegenerative Diseases 3.5 Major Downstream Buyers of Neurodegenerative Diseases Analysis 3.6 The Impact of Covid-19 From the Perspective of Industry Chain 3.7 Regional Import and Export Controls Will Exist for a Long Time 3.8 Continued downward PMI Spreads Globally 4 Global Neurodegenerative Diseases Market, by Type 4.1 Global Neurodegenerative Diseases Value and Market Share by Type (2015-2020) 4.2 Global Neurodegenerative Diseases Production and Market Share by Type (2015-2020) 4.3 Global Neurodegenerative Diseases Value and Growth Rate by Type (2015-2020) 4.3.1 Global Neurodegenerative Diseases Value and Growth Rate of NMDA 4.3.2 Global Neurodegenerative Diseases Value and Growth Rate of SSRIs 4.3.3 Global Neurodegenerative Diseases Value and Growth Rate of Dopamine Inhibitors 4.4 Global Neurodegenerative Diseases Price Analysis by Type (2015-2020) 5 Neurodegenerative Diseases Market, by Application 5.1 Downstream Market Overview 5.2 Global Neurodegenerative Diseases Consumption and Market Share by Application (2015-2020) 5.3 Global Neurodegenerative Diseases Consumption and Growth Rate by Application (2015-2020) 5.3.1 Global Neurodegenerative Diseases Consumption and Growth Rate of Parkinson’s Disease (2015-2020) 5.3.2 Global Neurodegenerative Diseases Consumption and Growth Rate of Huntington Disease (2015-2020) 5.3.3 Global Neurodegenerative Diseases Consumption and Growth Rate of Amyotrophic Lateral Sclerosis (2015-2020) 5.3.4 Global Neurodegenerative Diseases Consumption and Growth Rate of Alzheimer’s Disease (2015-2020) 6 Global Neurodegenerative Diseases Market Analysis by Regions 6.1 Global Neurodegenerative Diseases Sales, Revenue and Market Share by Regions 6.1.1 Global Neurodegenerative Diseases Sales by Regions (2015-2020) 6.1.2 Global Neurodegenerative Diseases Revenue by Regions (2015-2020) 6.2 North America Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 6.3 Europe Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 6.4 Asia-Pacific Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 6.5 Middle East and Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 6.6 South America Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 7 North America Neurodegenerative Diseases Market Analysis by Countries 7.1 The Influence of COVID-19 on North America Market 7.2 North America Neurodegenerative Diseases Sales, Revenue and Market Share by Countries 7.2.1 North America Neurodegenerative Diseases Sales by Countries (2015-2020) 7.2.2 North America Neurodegenerative Diseases Revenue by Countries (2015-2020) 7.3 United States Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 7.4 Canada Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 7.5 Mexico Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 8 Europe Neurodegenerative Diseases Market Analysis by Countries 8.1 The Influence of COVID-19 on Europe Market 8.2 Europe Neurodegenerative Diseases Sales, Revenue and Market Share by Countries 8.2.1 Europe Neurodegenerative Diseases Sales by Countries (2015-2020) 8.2.2 Europe Neurodegenerative Diseases Revenue by Countries (2015-2020) 8.3 Germany Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 8.4 UK Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 8.5 France Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 8.6 Italy Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 8.7 Spain Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 8.8 Russia Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 9 Asia Pacific Neurodegenerative Diseases Market Analysis by Countries 9.1 The Influence of COVID-19 on Asia Pacific Market 9.2 Asia Pacific Neurodegenerative Diseases Sales, Revenue and Market Share by Countries 9.2.1 Asia Pacific Neurodegenerative Diseases Sales by Countries (2015-2020) 9.2.2 Asia Pacific Neurodegenerative Diseases Revenue by Countries (2015-2020) 9.3 China Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 9.4 Japan Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 9.5 South Korea Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 9.6 India Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 9.7 Southeast Asia Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 9.8 Australia Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 10 Middle East and Africa Neurodegenerative Diseases Market Analysis by Countries 10.1 The Influence of COVID-19 on Middle East and Africa Market 10.2 Middle East and Africa Neurodegenerative Diseases Sales, Revenue and Market Share by Countries 10.2.1 Middle East and Africa Neurodegenerative Diseases Sales by Countries (2015-2020) 10.2.2 Middle East and Africa Neurodegenerative Diseases Revenue by Countries (2015-2020) 10.3 Saudi Arabia Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 10.4 UAE Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 10.5 Egypt Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 10.6 Nigeria Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 10.7 South Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 11 South America Neurodegenerative Diseases Market Analysis by Countries 11.1 The Influence of COVID-19 on Middle East and Africa Market 11.2 South America Neurodegenerative Diseases Sales, Revenue and Market Share by Countries 11.2.1 South America Neurodegenerative Diseases Sales by Countries (2015-2020) 11.2.2 South America Neurodegenerative Diseases Revenue by Countries (2015-2020) 11.3 Brazil Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 11.4 Argentina Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 11.5 Columbia Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 11.6 Chile Neurodegenerative Diseases Sales and Growth Rate (2015-2020) 12 Competitive Landscape 12.1 Biogen Idec 12.1.1 Biogen Idec Basic Information 12.1.2 Neurodegenerative Diseases Product Introduction 12.1.3 Biogen Idec Production, Value, Price, Gross Margin 2015-2020 12.2 Alector 12.2.1 Alector Basic Information 12.2.2 Neurodegenerative Diseases Product Introduction 12.2.3 Alector Production, Value, Price, Gross Margin 2015-2020 12.3 Bayer 12.3.1 Bayer Basic Information 12.3.2 Neurodegenerative Diseases Product Introduction 12.3.3 Bayer Production, Value, Price, Gross Margin 2015-2020 12.4 Asubio Pharmaceutical 12.4.1 Asubio Pharmaceutical Basic Information 12.4.2 Neurodegenerative Diseases Product Introduction 12.4.3 Asubio Pharmaceutical Production, Value, Price, Gross Margin 2015-2020 12.5 Addex Pharmaceutical 12.5.1 Addex Pharmaceutical Basic Information 12.5.2 Neurodegenerative Diseases Product Introduction 12.5.3 Addex Pharmaceutical Production, Value, Price, Gross Margin 2015-2020 12.6 Amarin 12.6.1 Amarin Basic Information 12.6.2 Neurodegenerative Diseases Product Introduction 12.6.3 Amarin Production, Value, Price, Gross Margin 2015-2020 12.7 Yumanity Therapeutics 12.7.1 Yumanity Therapeutics Basic Information 12.7.2 Neurodegenerative Diseases Product Introduction 12.7.3 Yumanity Therapeutics Production, Value, Price, Gross Margin 2015-2020 12.8 Pfizer 12.8.1 Pfizer Basic Information 12.8.2 Neurodegenerative Diseases Product Introduction 12.8.3 Pfizer Production, Value, Price, Gross Margin 2015-2020 12.9 Boehringer Ingelheim 12.9.1 Boehringer Ingelheim Basic Information 12.9.2 Neurodegenerative Diseases Product Introduction 12.9.3 Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020 12.10 UCB 12.10.1 UCB Basic Information 12.10.2 Neurodegenerative Diseases Product Introduction 12.10.3 UCB Production, Value, Price, Gross Margin 2015-2020 12.11 Merck 12.11.1 Merck Basic Information 12.11.2 Neurodegenerative Diseases Product Introduction 12.11.3 Merck Production, Value, Price, Gross Margin 2015-2020 12.12 AstraZeneca 12.12.1 AstraZeneca Basic Information 12.12.2 Neurodegenerative Diseases Product Introduction 12.12.3 AstraZeneca Production, Value, Price, Gross Margin 2015-2020 12.13 H.Lundbeck A/S 12.13.1 H.Lundbeck A/S Basic Information 12.13.2 Neurodegenerative Diseases Product Introduction 12.13.3 H.Lundbeck A/S Production, Value, Price, Gross Margin 2015-2020 12.14 Novartis 12.14.1 Novartis Basic Information 12.14.2 Neurodegenerative Diseases Product Introduction 12.14.3 Novartis Production, Value, Price, Gross Margin 2015-2020 12.15 Teva 12.15.1 Teva Basic Information 12.15.2 Neurodegenerative Diseases Product Introduction 12.15.3 Teva Production, Value, Price, Gross Margin 2015-2020 12.16 Eisai 12.16.1 Eisai Basic Information 12.16.2 Neurodegenerative Diseases Product Introduction 12.16.3 Eisai Production, Value, Price, Gross Margin 2015-2020 12.17 Bial 12.17.1 Bial Basic Information 12.17.2 Neurodegenerative Diseases Product Introduction 12.17.3 Bial Production, Value, Price, Gross Margin 2015-2020 13 Industry Outlook 13.1 Market Driver Analysis 13.1.2 Market Restraints Analysis 13.1.3 Market Trends Analysis 13.2 Merger, Acquisition and New Investment 13.3 News of Product Release 14 Global Neurodegenerative Diseases Market Forecast 14.1 Global Neurodegenerative Diseases Market Value & Volume Forecast, by Type (2020-2025) 14.1.1 NMDA Market Value and Volume Forecast (2020-2025) 14.1.2 SSRIs Market Value and Volume Forecast (2020-2025) 14.1.3 Dopamine Inhibitors Market Value and Volume Forecast (2020-2025) 14.2 Global Neurodegenerative Diseases Market Value & Volume Forecast, by Application (2020-2025) 14.2.1 Parkinson’s Disease Market Value and Volume Forecast (2020-2025) 14.2.2 Huntington Disease Market Value and Volume Forecast (2020-2025) 14.2.3 Amyotrophic Lateral Sclerosis Market Value and Volume Forecast (2020-2025) 14.2.4 Alzheimer’s Disease Market Value and Volume Forecast (2020-2025) 14.3 Neurodegenerative Diseases Market Analysis and Forecast by Region 14.3.1 North America Market Value and Consumption Forecast (2020-2025) 14.3.2 Europe Market Value and Consumption Forecast (2020-2025) 14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025) 14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025) 14.3.5 South America Market Value and Consumption Forecast (2020-2025) 15 New Project Feasibility Analysis 15.1 Industry Barriers and New Entrants SWOT Analysis 15.1.1 Porter’s Five Forces Analysis 15.1.2 New Entrants SWOT Analysis 15.2 Analysis and Suggestions on New Project Investment  

List of Tables and Figures Figure Product Picture of Neurodegenerative Diseases Table Product Specification of Neurodegenerative Diseases Table Neurodegenerative Diseases Key Market Segments Table Key Players Neurodegenerative Diseases Covered Figure Global Neurodegenerative Diseases Market Size, 2015 – 2025 Table Different Types of Neurodegenerative Diseases Figure Global Neurodegenerative Diseases Value ($) Segment by Type from 2015-2020 Figure Global Neurodegenerative Diseases Market Share by Types in 2019 Table Different Applications of Neurodegenerative Diseases Figure Global Neurodegenerative Diseases Value ($) Segment by Applications from 2015-2020 Figure Global Neurodegenerative Diseases Market Share by Applications in 2019 Figure Global Neurodegenerative Diseases Market Share by Regions in 2019 Figure North America Neurodegenerative Diseases Production Value ($) and Growth Rate (2015-2020) Figure Europe Neurodegenerative Diseases Production Value ($) and Growth Rate (2015-2020) Figure Asia Pacific Neurodegenerative Diseases Production Value ($) and Growth Rate (2015-2020) Figure Middle East and Africa Neurodegenerative Diseases Production Value ($) and Growth Rate (2015-2020) Figure South America Neurodegenerative Diseases Production Value ($) and Growth Rate (2015-2020) Table Global COVID-19 Status and Economic Overview Figure Global COVID-19 Status Figure COVID-19 Comparison of Major Countries Figure Industry Chain Analysis of Neurodegenerative Diseases Table Upstream Raw Material Suppliers of Neurodegenerative Diseases with Contact Information Table Major Players Headquarters, and Service Area of Neurodegenerative Diseases Figure Major Players Production Value Market Share of Neurodegenerative Diseases in 2019 Table Major Players Neurodegenerative Diseases Product Types in 2019 Figure Production Process of Neurodegenerative Diseases Figure Manufacturing Cost Structure of Neurodegenerative Diseases Figure Channel Status of Neurodegenerative Diseases Table Major Distributors of Neurodegenerative Diseases with Contact Information Table Major Downstream Buyers of Neurodegenerative Diseases with Contact Information Table Global Neurodegenerative Diseases Value ($) by Type (2015-2020) Table Global Neurodegenerative Diseases Value Share by Type (2015-2020) Figure Global Neurodegenerative Diseases Value Share by Type (2015-2020) Table Global Neurodegenerative Diseases Production by Type (2015-2020) Table Global Neurodegenerative Diseases Production Share by Type (2015-2020) Figure Global Neurodegenerative Diseases Production Share by Type (2015-2020) Figure Global Neurodegenerative Diseases Value ($) and Growth Rate of NMDA (2015-2020) Figure Global Neurodegenerative Diseases Value ($) and Growth Rate of SSRIs (2015-2020) Figure Global Neurodegenerative Diseases Value ($) and Growth Rate of Dopamine Inhibitors (2015-2020) Figure Global Neurodegenerative Diseases Price by Type (2015-2020) Figure Downstream Market Overview Table Global Neurodegenerative Diseases Consumption by Application (2015-2020) Table Global Neurodegenerative Diseases Consumption Market Share by Application (2015-2020) Figure Global Neurodegenerative Diseases Consumption Market Share by Application (2015-2020) Figure Global Neurodegenerative Diseases Consumption and Growth Rate of Parkinson’s Disease (2015-2020) Figure Global Neurodegenerative Diseases Consumption and Growth Rate of Huntington Disease (2015-2020) Figure Global Neurodegenerative Diseases Consumption and Growth Rate of Amyotrophic Lateral Sclerosis (2015-2020) Figure Global Neurodegenerative Diseases Consumption and Growth Rate of Alzheimer’s Disease (2015-2020) Figure Global Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Global Neurodegenerative Diseases Revenue (M USD) and Growth (2015-2020) Table Global Neurodegenerative Diseases Sales by Regions (2015-2020) Table Global Neurodegenerative Diseases Sales Market Share by Regions (2015-2020) Table Global Neurodegenerative Diseases Revenue (M USD) by Regions (2015-2020) Table Global Neurodegenerative Diseases Revenue Market Share by Regions (2015-2020) Table Global Neurodegenerative Diseases Revenue Market Share by Regions in 2015 Table Global Neurodegenerative Diseases Revenue Market Share by Regions in 2019 Figure North America Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Europe Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Asia-Pacific Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Middle East and Africa Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure South America Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure North America COVID-19 Status Figure North America COVID-19 Confirmed Cases Major Distribution Figure North America Neurodegenerative Diseases Revenue (M USD) and Growth (2015-2020) Table North America Neurodegenerative Diseases Sales by Countries (2015-2020) Table North America Neurodegenerative Diseases Sales Market Share by Countries (2015-2020) Table North America Neurodegenerative Diseases Revenue (M USD) by Countries (2015-2020) Table North America Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020) Figure United States Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Canada Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Mexico Neurodegenerative Diseases Sales and Growth (2015-2020) Figure Europe COVID-19 Status Figure Europe COVID-19 Confirmed Cases Major Distribution Figure Europe Neurodegenerative Diseases Revenue (M USD) and Growth (2015-2020) Table Europe Neurodegenerative Diseases Sales by Countries (2015-2020) Table Europe Neurodegenerative Diseases Sales Market Share by Countries (2015-2020) Table Europe Neurodegenerative Diseases Revenue (M USD) by Countries (2015-2020) Table Europe Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020) Figure Germany Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure UK Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure France Neurodegenerative Diseases Sales and Growth (2015-2020) Figure Italy Neurodegenerative Diseases Sales and Growth (2015-2020) Figure Spain Neurodegenerative Diseases Sales and Growth (2015-2020) Figure Russia Neurodegenerative Diseases Sales and Growth (2015-2020) Figure Asia Pacific COVID-19 Status Figure Asia Pacific Neurodegenerative Diseases Revenue (M USD) and Growth (2015-2020) Table Asia Pacific Neurodegenerative Diseases Sales by Countries (2015-2020) Table Asia Pacific Neurodegenerative Diseases Sales Market Share by Countries (2015-2020) Table Asia Pacific Neurodegenerative Diseases Revenue (M USD) by Countries (2015-2020) Table Asia Pacific Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020) Figure China Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Japan Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure South Korea Neurodegenerative Diseases Sales and Growth (2015-2020) Figure India Neurodegenerative Diseases Sales and Growth (2015-2020) Figure Southeast Asia Neurodegenerative Diseases Sales and Growth (2015-2020) Figure Australia Neurodegenerative Diseases Sales and Growth (2015-2020) Figure Middle East Neurodegenerative Diseases Revenue (M USD) and Growth (2015-2020) Table Middle East Neurodegenerative Diseases Sales by Countries (2015-2020) Table Middle East and Africa Neurodegenerative Diseases Sales Market Share by Countries (2015-2020) Table Middle East and Africa Neurodegenerative Diseases Revenue (M USD) by Countries (2015-2020) Table Middle East and Africa Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020) Figure Saudi Arabia Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure UAE Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Egypt Neurodegenerative Diseases Sales and Growth (2015-2020) Figure Nigeria Neurodegenerative Diseases Sales and Growth (2015-2020) Figure South Africa Neurodegenerative Diseases Sales and Growth (2015-2020) Figure South America Neurodegenerative Diseases Revenue (M USD) and Growth (2015-2020) Table South America Neurodegenerative Diseases Sales by Countries (2015-2020) Table South America Neurodegenerative Diseases Sales Market Share by Countries (2015-2020) Table South America Neurodegenerative Diseases Revenue (M USD) by Countries (2015-2020) Table South America Neurodegenerative Diseases Revenue Market Share by Countries (2015-2020) Figure Brazil Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Argentina Neurodegenerative Diseases Sales and Growth Rate (2015-2020) Figure Columbia Neurodegenerative Diseases Sales and Growth (2015-2020) Figure Chile Neurodegenerative Diseases Sales and Growth (2015-2020) Figure Top 3 Market Share of Neurodegenerative Diseases Companies in 2019 Figure Top 6 Market Share of Neurodegenerative Diseases Companies in 2019 Table Major Players Production Value ($) Share (2015-2020) Table Biogen Idec Profile Table Biogen Idec Product Introduction Figure Biogen Idec Production and Growth Rate Figure Biogen Idec Value ($) Market Share 2015-2020 Table Alector Profile Table Alector Product Introduction Figure Alector Production and Growth Rate Figure Alector Value ($) Market Share 2015-2020 Table Bayer Profile Table Bayer Product Introduction Figure Bayer Production and Growth Rate Figure Bayer Value ($) Market Share 2015-2020 Table Asubio Pharmaceutical Profile Table Asubio Pharmaceutical Product Introduction Figure Asubio Pharmaceutical Production and Growth Rate Figure Asubio Pharmaceutical Value ($) Market Share 2015-2020 Table Addex Pharmaceutical Profile Table Addex Pharmaceutical Product Introduction Figure Addex Pharmaceutical Production and Growth Rate Figure Addex Pharmaceutical Value ($) Market Share 2015-2020 Table Amarin Profile Table Amarin Product Introduction Figure Amarin Production and Growth Rate Figure Amarin Value ($) Market Share 2015-2020 Table Yumanity Therapeutics Profile Table Yumanity Therapeutics Product Introduction Figure Yumanity Therapeutics Production and Growth Rate Figure Yumanity Therapeutics Value ($) Market Share 2015-2020 Table Pfizer Profile Table Pfizer Product Introduction Figure Pfizer Production and Growth Rate Figure Pfizer Value ($) Market Share 2015-2020 Table Boehringer Ingelheim Profile Table Boehringer Ingelheim Product Introduction Figure Boehringer Ingelheim Production and Growth Rate Figure Boehringer Ingelheim Value ($) Market Share 2015-2020 Table UCB Profile Table UCB Product Introduction Figure UCB Production and Growth Rate Figure UCB Value ($) Market Share 2015-2020 Table Merck Profile Table Merck Product Introduction Figure Merck Production and Growth Rate Figure Merck Value ($) Market Share 2015-2020 Table AstraZeneca Profile Table AstraZeneca Product Introduction Figure AstraZeneca Production and Growth Rate Figure AstraZeneca Value ($) Market Share 2015-2020 Table H.Lundbeck A/S Profile Table H.Lundbeck A/S Product Introduction Figure H.Lundbeck A/S Production and Growth Rate Figure H.Lundbeck A/S Value ($) Market Share 2015-2020 Table Novartis Profile Table Novartis Product Introduction Figure Novartis Production and Growth Rate Figure Novartis Value ($) Market Share 2015-2020 Table Teva Profile Table Teva Product Introduction Figure Teva Production and Growth Rate Figure Teva Value ($) Market Share 2015-2020 Table Eisai Profile Table Eisai Product Introduction Figure Eisai Production and Growth Rate Figure Eisai Value ($) Market Share 2015-2020 Table Bial Profile Table Bial Product Introduction Figure Bial Production and Growth Rate Figure Bial Value ($) Market Share 2015-2020 Table Market Driving Factors of Neurodegenerative Diseases Table Merger, Acquisition and New Investment Table Global Neurodegenerative Diseases Market Value ($) Forecast, by Type Table Global Neurodegenerative Diseases Market Volume Forecast, by Type Figure Global Neurodegenerative Diseases Market Value ($) and Growth Rate Forecast of NMDA (2020-2025) Figure Global Neurodegenerative Diseases Market Volume ($) and Growth Rate Forecast of NMDA (2020-2025) Figure Global Neurodegenerative Diseases Market Value ($) and Growth Rate Forecast of SSRIs (2020-2025) Figure Global Neurodegenerative Diseases Market Volume ($) and Growth Rate Forecast of SSRIs (2020-2025) Figure Global Neurodegenerative Diseases Market Value ($) and Growth Rate Forecast of Dopamine Inhibitors (2020-2025) Figure Global Neurodegenerative Diseases Market Volume ($) and Growth Rate Forecast of Dopamine Inhibitors (2020-2025) Table Global Market Value ($) Forecast by Application (2020-2025) Table Global Market Volume Forecast by Application (2020-2025) Figure Market Value ($) and Growth Rate Forecast of Parkinson’s Disease (2020-2025) Figure Market Volume and Growth Rate Forecast of Parkinson’s Disease (2020-2025) Figure Market Value ($) and Growth Rate Forecast of Huntington Disease (2020-2025) Figure Market Volume and Growth Rate Forecast of Huntington Disease (2020-2025) Figure Market Value ($) and Growth Rate Forecast of Amyotrophic Lateral Sclerosis (2020-2025) Figure Market Volume and Growth Rate Forecast of Amyotrophic Lateral Sclerosis (2020-2025) Figure Market Value ($) and Growth Rate Forecast of Alzheimer’s Disease (2020-2025) Figure Market Volume and Growth Rate Forecast of Alzheimer’s Disease (2020-2025) Figure North America Market Value ($) and Growth Rate Forecast (2020-2025) Figure North America Consumption and Growth Rate Forecast (2020-2025) Figure Europe Market Value ($) and Growth Rate Forecast (2020-2025) Figure Europe Consumption and Growth Rate Forecast (2020-2025) Figure Asia Pacific Market Value ($) and Growth Rate Forecast (2020-2025) Figure Asia Pacific Consumption and Growth Rate Forecast (2020-2025) Figure Middle East and Africa Market Value ($) and Growth Rate Forecast (2020-2025) Figure Middle East and Africa Consumption and Growth Rate Forecast (2020-2025) Figure South America Market Value ($) and Growth Rate Forecast (2020-2025) Figure South America Consumption and Growth Rate Forecast (2020-2025) Figure Porter’s Five Forces Analysis Table New Entrants SWOT Analysis Table New Project Analysis of Investment Recovery

CHOOSE LICENCE TYPE

TESTIMONIALS

What amazed me most was the professionalism and client satisfaction provided by Garner Insights. Their responses were quick and actioned on immediately.

Sr. Manager
A UK based manufacturing firm

I would like to thank the team at Garner Insights, you guys made my job so easier with your spoon fed service and quality market study.

President
At a US based consulting firm

The team of Garner Insights solved my queries in a timely fashion and gracefully. I have purchased reports from them a few times now and they never cease to impress with their highly intellectual team.

Marketing Manager
At a Fortune 100 pharmaceutical firm

I had some issues with the payment gateway and almost the immediate second I get a call from one of the enthusiastic sales member who guided me throughout the process and also reassured me of the next steps.

A Consultant
At a German based retail firm

The quality of data encompassed in the report was very useful for me in my marketing strategy needs

Director of Marketing
At a US based Manufacturing firm

What's Included

  • Market Size
  • Market Share
  • Market Segmentation
  • Market Forecast
  • Regional Segment Analysis
  • Compound Annual Growth Rate
  • Company & Brand Details
  • Market Revenue and Growth Opportunities
  • Safe and Secure

FAQ's

By product type
By End User/Applications
By Technology
By Leading Industry Players
By Region
We will send you an email with login credentials to access the report. You will also be able to download the pdf.
The study on the impact of COVID-19 on the global market is classified into different segments and analysed based on regions, including North America, Europe, Asia-Pacific, and Rest of World.

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology

OUR CLIENTS

product product product product product product

OR
CHOOSE LICENCE TYPE

Every Sample
Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology